As investor dollars that funded its creation and growth are now demanding profitability — just as they did for its predecessors — signals will emerge from the noise.
Italy’s Guardia di Finanza is alleging that Pfizer’s unit, Pfizer Italia Srl, transferred excess capital to affiliates in the U.S. and the Netherlands to avoid taxes on profits